BX Lab

Halogenated Nucleosides

9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine

Quick view. We supply 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. CAS 1612191-95-3. Catalog target purity: Specification on request.

Structure and identity

The structure drawing for this item is being finalized. Use the CAS number and machine-readable identifiers below to confirm the requested protecting groups, stereochemistry, salt or counterion and hydration state before ordering.

Identifiers available

CAS, molecular formula, SMILES or InChI data are shown below when available.

Identity control

We withhold a drawing when a related compound, alternate salt or incompletely specified stereoisomer could be mistaken for the requested material.

Qualification output

Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.

Catalog numberBX-HN-0051
CAS number1612191-95-3
PuritySpecification on request
Pack sizeCustomized to customer requirements

Product profile

Material identity

9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine is classified as nucleoside or protected nucleoside intermediate (Formula C18H16FN5O3; molecular weight 369.36).

Typical application

9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.

Handling focus

For 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine, coupling, deprotection and biological performance remain sequence- and position-dependent.

Names and search terms

Confirmed or normalized name variants

Useful catalog search terms

Physicochemical data

Boiling point704.5±70.0 °C(Predicted)
Density1.53±0.1 g/cm3(Predicted)
pKa12.42±0.70(Predicted)

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Additional application examples

Product-specific evaluation notes

Potential advantages

Method limitations

These points describe 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine or its named chemical feature. Broader product-family guidance is maintained on the category page.

Related products

Frequently asked questions

Can the package size for 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine be customized?

Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.

What information should be included in a quote request?

Quote catalog number BX-HN-0051 and CAS 1612191-95-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.

Product-family literature

The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.

Request a quote